Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia.

Today most patients with congenital heart defects (CHD) survive into adulthood. Unfortunately, despite relevant residua and sequels, follow-up care of adults with congenital heart disease (ACHD) is not performed in specialized and/or certified physicians or centres. Major problems in the long-term course encompass heart failure, cardiac arrhythmias, heart valve disorders, pulmonary vascular disease, infective endocarditis, aortopathy and non-cardiac comorbidities. Many of them manifest themselves differently from acquired heart disease and therapy regimens from general cardiology cannot be transferred directly to CHD. It should be noted that even simple, postoperative heart defects that were until recently considered to be harmless can lead to problems with age, a fact that had not been expected so far. The treatment of ACHD has many special features and requires special expertise. Thereby, it is important that treatment regimens from acquired heart disease are not necessarily transmitted to CHD. While primary care physicians have the important and responsible task to set the course for adequate diagnosis and treatment early and to refer patients to appropriate care in specialized ACHD-facilities, they should actively encourage ACHD to pursue follow-up care in specialized facilities who can provide responsible and advanced advice. This medical update emphasizes the current data on epidemiology, heart failure and cardiac arrhythmia in ACHD.

[1]  Stephanie Fuller,et al.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Circulation.

[2]  R. Oberhoffer,et al.  Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients. , 2018, Cardiovascular diagnosis and therapy.

[3]  D. Celermajer,et al.  Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease , 2018, European journal of heart failure.

[4]  J. Mulder,et al.  Current state of risk stratification for sudden cardiac death in adults with congenital heart disease , 2018, Anatolian journal of cardiology.

[5]  I. V. Van Gelder,et al.  Cardiac resynchronization therapy in adults with congenital heart disease , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  G. Diller,et al.  Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management , 2018, Circulation.

[7]  D. Negura,et al.  Heart failure in grown-up congenital heart disease. , 2018, Minerva cardioangiologica.

[8]  D. Morales,et al.  Overview of adult congenital heart transplants. , 2018, Annals of cardiothoracic surgery.

[9]  D. Celermajer,et al.  Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. , 2017, International journal of cardiology.

[10]  Joseph D. Kay,et al.  Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation.

[11]  S. Kutty,et al.  An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  O. Ziff,et al.  Digoxin: The good and the bad. , 2016, Trends in cardiovascular medicine.

[13]  J. Triedman,et al.  Trends in Congenital Heart Disease: The Next Decade , 2016, Circulation.

[14]  O. Tutarel,et al.  Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. , 2016, International journal of cardiology.

[15]  A. Niesert,et al.  Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease. , 2016, The American journal of cardiology.

[16]  K. Dimopoulos,et al.  Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P. , 2016, Expert review of cardiovascular therapy.

[17]  R. Ohye,et al.  Berlin heart ventricular assist device as a long‐term bridge to transplantation in a Fontan patient with failing single ventricle , 2015, Pediatric transplantation.

[18]  S. Hohnloser,et al.  Digoxin-associated mortality: a systematic review and meta-analysis of the literature. , 2015, European heart journal.

[19]  P. Robinson,et al.  The Application of Clinical Genetics Dovepress Perspectives on the Revised Ghent Criteria for the Diagnosis of Marfan Syndrome , 2022 .

[20]  K. Liestøl,et al.  Achievements in congenital heart defect surgery: a prospective, 40-year study of 7038 patients. , 2015, Circulation.

[21]  G. MacGowan,et al.  Durable ventricular assist device support for failing systemic morphologic right ventricle: early results. , 2014, The Annals of thoracic surgery.

[22]  Nandini Dendukuri,et al.  Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.

[23]  M. Abrahamowicz,et al.  Specialized Adult Congenital Heart Disease Care: The Impact of Policy on Mortality , 2014, Circulation.

[24]  D. Driscoll,et al.  Cardiac and multiorgan transplantation for end-stage congenital heart disease. , 2014, Mayo Clinic proceedings.

[25]  D. Grobbee,et al.  Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. , 2013, International journal of cardiology.

[26]  U. Bauer,et al.  [Adults with congenital heart disease: treatment and medical problems]. , 2013, Herz.

[27]  J. Hoffman The global burden of congenital heart disease , 2013, Cardiovascular journal of Africa.

[28]  J. Moriarty,et al.  Efficacy of endothelin blockade in adults with Fontan physiology. , 2013, Congenital Heart Disease.

[29]  S. Qureshi,et al.  Association for European Paediatric and Congenital Cardiology , 2012, Cardiology in the Young.

[30]  J. Roos‐Hesselink,et al.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.

[31]  R. Davies,et al.  Listing and Transplanting Adults With Congenital Heart Disease , 2011, Circulation.

[32]  M. Abrahamowicz,et al.  Changing mortality in congenital heart disease. , 2010, Journal of the American College of Cardiology.

[33]  D. Grobbee,et al.  Mortality in adult congenital heart disease. , 2010, European heart journal.

[34]  J. Hess,et al.  [Congenital heart disease. Transition from adolescence to adulthood]. , 2009, Der Internist.

[35]  B. Diggs,et al.  National Practice Patterns for Management of Adult Congenital Heart Disease: Operation By Pediatric Heart Surgeons Decreases In-Hospital Death , 2008, Circulation.

[36]  Geoffrey I. Webb,et al.  Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. , 2008, International journal of cardiology.

[37]  H. Sairanen,et al.  Causes of late deaths after pediatric cardiac surgery: a population-based study. , 2007, Journal of the American College of Cardiology.

[38]  J. Child,et al.  The adult with a Fontan operation , 2007, Current cardiology reports.

[39]  A. Ducharme,et al.  Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial , 2005, Circulation.

[40]  C. Warnes,et al.  The adult with congenital heart disease: born to be bad? , 2005, Journal of the American College of Cardiology.

[41]  J. Hess,et al.  Surgical treatment of patent ductus arteriosus: a new historical perspective. , 2004, The American journal of cardiology.

[42]  R. Quaife,et al.  Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  J. W. Moore,et al.  Afterload Reduction Therapy in Patients Following Intraatrial Baffle Operation for Transposition of the Great Arteries , 2002, Pediatric Cardiology.

[44]  S. Siu,et al.  Heart Failure and Ventricular Dysfunction in Patients With Single or Systemic Right Ventricles , 2002, Circulation.

[45]  E. Foster,et al.  Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. , 2001, The American journal of cardiology.

[46]  C A Warnes,et al.  Challenges posed by adults with repaired congenital heart disease. , 2001, Circulation.

[47]  Geoffrey I. Webb,et al.  Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. , 2001, The American journal of cardiology.

[48]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[49]  V. McKusick,et al.  Life expectancy and causes of death in the Marfan syndrome. , 1972, The New England journal of medicine.

[50]  P. Eghtesady,et al.  Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[51]  W. Budts,et al.  Management of acute heart failure in adult patients with congenital heart disease , 2017, Heart Failure Reviews.

[52]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[53]  Gianfranco Ferrari,et al.  Hemodynamic Effects of Ventricular Assist Device Implantation on Norwood, Glenn, and Fontan Circulation: A Simulation Study. , 2016, Artificial organs.

[54]  J. Hess,et al.  [Adult patients with congenital heart abnormalities: present and future]. , 2005, Deutsche medizinische Wochenschrift.

[55]  J. Stark Do we really correct congenital heart defects? , 1989, Journal of Thoracic and Cardiovascular Surgery.